We demonstrated that, in distinction to classical opioid receptors, ACKR3 doesn't induce classical G protein signaling and isn't modulated via the classical prescription or analgesic opioids, which include morphine, fentanyl, or buprenorphine, or by nonselective opioid antagonists which include naloxone. Instead, we established that LIH383, an ACKR3-selective subnanomolar competitor https://jimp517hzp3.salesmanwiki.com/user